|
Trials Starting With "P" |
PACCOCATH ISR 1: Treatment of In-Stent Restenosis by Paclitaxel-Coated PTCA Balloons
-Tiral Overview by Dr. Bruno Scheller (AHA 2006)
PACCOCATH ISR 1 and 2: Efficacy and Safety of Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis
-2-Year Results by Dr. Bruno Scheller (TCT 2007)
PAMI: The Primary Angioplasty In Myocardial Infarction Study
-Role of Stenting in Acute MI: PAMI Stent Pilot Trial
PARTNER: A Prospective Randomized Trial of Transcatheter Aortic Valve Implantation Compared to Standard Therapy in Patients with Inoperable Aortic stenosis
-A Prospective Randomized Trial of Transcatheter Aortic Valve Implantation Compared to Standard Therapy in Patients with Inoperable Aortic Stenosis by Dr. Martin Leon (TCT 2010)
PASEO: Paclitaxel- or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty
-Long-term Outcome of Drug-eluting Stents Compared with Bare Metal Stents in ST-segment Elevation Myocardial Infarction by Dr. Emilio Di Lorenzo
PCI-CURE: Effects Of Pretreatment With Clopidogrel And Aspirin Followed By Long-Term Therapy In Patients Undergoing Percutaneous Coronary Intervention:
-Trial Overview by Dr. Maurits T. Dirksen (AHA 2006)
PCI ExTRACT-TIMI 25: PCI in Patients Receiving Enoxaparin or UFH Following Fibrinolytic Therapy for STEMI
-Trial Overview by Dr. C. Michael Gibson (AHA 2006)
PC: Physical Counterpressure Manoeuvre Trial
-Trial Overview by Dr. N. van Dijk (ACC 2006)
PEACE: Prevention of Events with Angiotensin Converting Enzyme Inhibition
-Trial Overview by Dr. M. Pheffer (AHA 2004)
-Prognostic Value of B-Type Natriuretic Peptides in Patients with Stable Coronary Artery Disease by Dr. T. Omland
PEECH: Prospective Evaluation of EECP in Congestive Heart Failure
-Trial Overview by Dr. Arthur M. Feldman (ACC 2005)
PEPCAD II ISR: Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease
PERfECT STENT: Paclitaxel-Eluting Balloon in Patients Treated with Endothelial Progenitor Cell Capturing Stents for De Novo Coronary Artery Disease
-A Prospective, Randomized Trail Evaluating a Paclitaxel-Eluting Balloon in Patients Treated with Endothelial Progenitor Cell Capturing Stents for De Novo Coronary Artery Disease by Dr. Jochen Wohrle (TCT 2010)
Periprocedural MI: Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions
-Paclitaxel-eluting devices: randomized comparison of the SeQuent™ please balloon catheter versus the TAXUS stent in the treatment of in-stent restenosis – 12 month follow-up of the PEPCAD II ISR study by Dr. Abhiram Prasad (TCT 2008)
PERISCOPE: Pioglitazone Effect On Regression Of Intravascular Sonographic Coronary Obstruction Prospective Evaluation
-Comparison of Pioglitazone vs. Glimepiride on Progression of Coronary Atherosclerosis in Patients with Type 2 Diabetes by Dr. Steven E. Nissen
PFO Closure: PFO Closure Compared to Medical Therapy in Patients wirh Stroke related to PFO
-A Prospective, Nonrandomized, Propensity-Adjusted Study of PFO Closure Compared to Medical Therapy in Patients with Stroke Presumably Related to PFO by Dr. Bernhard Meier
Pioglitazone: Pioglitazone Reduces Neointima Formation After Coronary Stent Implantation
-Trial Overview by Dr. Nikolaus Marx (TCT 2005)
PIOSTAT: Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein
-Trial Overview by Dr. Markolf Hanefeld (TCT 2005)
PLATO: the PLATelet Inhibition and and patient Outcomes trial- Ticagrelor compared with Clopidogrel in Patients with Acute Coronary Syndromes
-Trial Overview by Dr. Lars Wallentin
-Outcomes in Patients with a Planned Invasive Strategy by Dr. Christopher Cannon
PLUS: Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein
-Ultrasound-Facilitated Thrombolysis by Dr. Douglas Weaver
Post-conditioning the human heart to reduce infarct size
-Trial Overview by Dr. Douglas Weaver
PRAGUE-2: Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis
PREAMI: Perindopril Remodeling In Elderly With Acute Myocardial Infarction
-Trial Overview by Dr. Roberto Ferrari (ESC 2005)
PREDICTION: PREDICTION of Progression of Coronary Artery Disease and Clinical Outcomes Using Vascular Profiling of Shear Stress and Wall Morphology
-Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling by Dr. Peter H. Stone
PREMIER: Effects Of Pg-116800, A Matrix Metalloproteinase Inhibitor, To Prevent Left Ventricular Remodeling After Acute Myocardial Infarction
-Protection from Distal Embolization in High-Risk Patients With Acute ST-Segment Elevation Myocardial Infarction (PREMIAR) Trial by Dr. F. Cura (ACC 2008)
PREMIAR: Protection From Distal Embolization In High-Risk Patients With Acute St-Segment Elevation Myocardial Infarction
-Trial Overview by Dr. F. Cura (ACC 2008)
PREPARE: Proximal Embolic Protection in Acute MI and Resolution of ST-Elevation
-A Prospective Randomized Trial of Proximal Microcirculatory Protection in Patients with Acute Myocardial Infarction Undergoing Primary PCI by Dr. Karel T. Koch (TCT 2008)
-Randomized Comparison of Primary PCI with Combined Proximal Embolic Protection and Thrombus Aspiration versus Primary PCI Alone in STEMI by Dr. Joost D.E. Haeck
PREVENT: Prevention of Recurrent Venous Thromboembolism
PREVENT-ICARUS: Intracoronary Adenosine to Prevent Periprocedural Myonecrosis in Patients Undergoing Elective Coronary Angioplasty
-A Prospective, Randomized, Double-Blind Trial of Intracoronary Adenosine to Prevent Periprocedural Myonecrosis in Patients Undergoing Elective Coronary Angioplasty by Dr. Giuseppe De Luca
PRIMO-CABG II: Pexelizumab for the Reduction of Infarction and Mortality in Coronary Artery Bypass Graft ll
-Trial Overview by Dr. PA Gladding
PRINC: The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: the Plavix Response in Coronary Intervention
-Trial Overview by Dr. Peter K. Smith (ACC 2006)
PRINCIPLE: Prasugrel In Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation
-Trial Overview by Dr. SD Wiviott
PRISM-PLUS: Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
-PRISM-PLUS: Patients with Diabetes
PROactive: Prospective Pioglitazone Clinical Trial in Macrovascular Events
-Trial Overview by Professor Ele Ferrannini (EASD 2005)
PROBI VIRI: Prolonged Bivalirudin Infusion Versus Intraprocedural only Randomized Study
-Trial Overview by Dr. Bernardo Cotese (TCT 2008)
PRoFESS: Prevention Regimen For Effectively avoiding Second Strokes
-Trial Overview by Dr. Ralph Sacco, Dr. Salim Yusuf, Dr. Hans-Christof Diener (European Stroke Conference 2008)
PRO-GR: High-Dose Clopidogrel vs. Prasugrel in Clopidogrel Resistant Patients With and Without the CYP2C19*2 Loss-of-Function Allele
- A Prospective, Randomized, Crossover Study of Maintenance High-Dose Clopidogrel vs. Prasugrel in Clopidogrel Resistant Patients With and Without the CYP2C19*2 Loss-of-Function Allele by Dr. Dimitrios Alexopoulos (TCT 2010)
PROGRESS-1: Clinical Performance and Angiographic Results of the Coronary Stenting with Absorbable Metal Stents
-First-in-Man Study of an Absorbable Stent by Dr. Raimund Erbel (ACC 2006)
Progress-AMS: Clinical Performance and Angiographic Results of the Coronary Stenting with Absorbable Metal Stents
-New Stent Technology: Magnesium-alloy by Dr. Raimund Erbel
PROMISE: Protection Devices In Pci-Treatment Of Myocardial Infarction For Salvage Of Endangered Myocardium Study
-Trial Overview by Dr. Michael Glickl (ACC 2005)
PROSPECT: Predictors of Response to CRT
-Trial Overview by Dr. Stefano Ghio
PROSPECT: Providing Regional Observations to Study Predictors of Events in the Coronary Tree
-A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque by Dr. Gregg W. Stone (TCT 2009)
PROSPER: Pravastatin in Elderly Individuals at Risk for Vascular Disease
-Late Breaking Clinical Trials (AHA 2002)
PROTECT-TIMI 30: Randomized Trial To Evaluate The Relative Protection Against Post-Pci Microvascular Dysfunction And Post-Pca Ischemia Among Anti-Platelet And Anti-Thrombotic Agents
-Late Breaking Clinical Trials (AHA 2005)
PROTECT AF: Percutaneous Closure of the Left Atrial Appendage versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation: A Randomized Non-Inferiority Trial
-Trial Overview by Dr. David R. Holmes (AHA 2002)
PROVE IT-TIMI 22: Pravastatin or Atorvastatin Evaluation and Infection Therapy
-Late Breaking Clinical Trial by Dr. Christopher P. Cannon (ACC 2004)
PROVIDENCE: Prospective Evaluation of Rifalazil Effect On Vascular Symptoms of Intermittent Claudication and Other Endpoints in Chlamydia Seropositive Patients
-Trial Overview by Dr. Michael R. Jaff (AHA 2007)
Who Are We? Slide Downloading Policy Financial Disclosure We Do Not Promote Off Label Product Use Copyright Source of Slides Editorial Policy Links Policy Privacy Policy Access CME Programs
© 1999-2009 by Clinical Trial Results .org. None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results. All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster